Study | Clinical outcomes | Results | P-value(s) |
---|---|---|---|
Hale et al. [15], USA | Hospitalisations ED visits | Number of participants who had one or more HF-related hospitalisations were 4 in intervention group versus 1 in control group and non-HF related hospitalisations were 1 in intervention group versus 4 in control group after 90 days. All-cause hospital admissions were significant, with 1 in intervention group versus 4 in control group Number of participants who had one or more HF-related ED visits were 1 in intervention group versus 3 in control group and non-HF related ED visits were 3 in intervention group versus 4 in control group after 90 days. All-cause ED visits were not significant, with 3 in the intervention group versus 6 in the control group | 0.340 (HF), 0.340 (non-HF), 0.040 (all-cause) 0.600 (HF), 0.990 (non-HF), 0.680 (all-cause) |
Gallagher et al. [16], USA | 30-day all cause readmission | Number of readmissions were 6 in the intervention group and 4 in the control group after 30 days follow-up | 0.720 |
Wu et al. [19], USA | Cardiac event-free survival (Including ED visit, hospitalization, death) | Event-free survival was significantly longer for the patients in both intervention groups than the control | 0.010 |
Yanicelli et al. [21], Argentina | Rehospitalisation (from electronic medical record) | Number of rehospitalisation were 0 for intervention group and 2 in control group after 3 months follow-up | 0.500 |
Young et al. [22], USA | All-cause readmissions ED visits | Number of participants readmitted to hospital was 10 for intervention group versus 3 in the control group Number of participants admitted for ED visits at 90 days were 9 for intervention group versus 11 in control group | 0.088 |